Gestational Trophoblastic Tumor Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Dostarlimab in Chemoresistant Gestational Trophoblastic Neoplasia
Condition: Gestational Trophoblastic Neoplasia Intervention: Drug: Dostarlimab Sponsors: University of Miami; GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 6, 2022 Category: Research Source Type: clinical trials
Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia
Condition: Gestational Trophoblastic Neoplasia Interventions: Drug: Camrelizumab plus apatinib CohortA; Drug: Camrelizumab plus apatinib Cohort B Sponsors: Peking Union Medical College Hospital; Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2021 Category: Research Source Type: clinical trials
